Inventor
KISHIMOTO TADAMITSU
JP41 patents
⚠️ This page may combine multiple inventors who share the name “KISHIMOTO TADAMITSU”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
KISHIMOTO TADAMITSU
11 patentsUS5171840ADec 15, 1992
Receptor protein for human B cell stimulatory factor-2
KISHIMOTO TADAMITSU49 citations96
US5844082ADec 1, 1998
Human acute phase response factor
KISHIMOTO TADAMITSU25 citations92
US8119126B2Feb 21, 2012
Inhibiting vascularization using antibodies to CXCR4 and SDF-1
KISHIMOTO TADAMITSU6 citations81
US5719042AFeb 17, 1998
Nucleic acids encoding transcription factor APRF (acute phase response factor)
KISHIMOTO TADAMITSU16 citations81
US5132403AJul 21, 1992
Human gp130 protein
KISHIMOTO TADAMITSU17 citations74
US6514725B1Feb 4, 2003
STAT function-regulatory protein
KISHIMOTO TADAMITSU11 citations71
US5360894ANov 1, 1994
C/EBP2 gene and recombinant C/EBP2
KISHIMOTO TADAMITSU6 citations70
US5215892AJun 1, 1993
C/EBP2 gene and recombinant C/EBP2
KISHIMOTO TADAMITSU11 citations70
US5223611AJun 29, 1993
DNA encoding for human GP130 protein
KISHIMOTO TADAMITSU5 citations63
US10550387B2Feb 4, 2020
Therapeutic agent for a lung disease and/or method for screening for the same
KISHIMOTO TADAMITSU1 citations62
US7247424B2Jul 24, 2007
Screening method for a substance having hypoglycemic activity by using STAT-induced inhibitor of STAT function-1
KISHIMOTO TADAMITSU0 citations50
(unassigned)
6 patentsUS5670373ASep 23, 1997
Antibody to human interleukin-6 receptor
270 citations99
US6410691B1Jun 25, 2002
Receptor protein for human B cell stimulatory factor-2
82 citations98
US5990282ANov 23, 1999
Receptor protein for human B cell stimulatory factor-2
45 citations96
US5851793ADec 22, 1998
Recombinant DNA encoding receptor protein for human B-cell stimulatory factor-2
48 citations96
US5480796AJan 2, 1996
Antibodies against the receptor protein for human B cell stimulatory factor-2
67 citations96
US6428979B1Aug 6, 2002
Receptor protein for human B cell stimulatory factor-2
53 citations93
CHUGAI PHARMACEUTICAL CO LTD
5 patentsUS7320792B2Jan 22, 2008
Preventives or remedies for psoriasis containing as the active ingredient IL-6 antagonist
CHUGAI PHARMACEUTICAL CO LTD147 citations98
US6723319B1Apr 20, 2004
Method of treating inflammatory intestinal diseases containing as the ingredient IL-6 receptors antibodies
CHUGAI PHARMACEUTICAL CO LTD240 citations97
US5888510AMar 30, 1999
Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component
CHUGAI PHARMACEUTICAL CO LTD285 citations97
US7824674B2Nov 2, 2010
Preventive or therapeutic agent for inflammatory bowel disease comprising IL-6 antagonist as an active ingredient
CHUGAI PHARMACEUTICAL CO LTD89 citations96
US11279931B2Mar 22, 2022
Therapeutic agent for a lung disease and/or method for screening for the same
CHUGAI PHARMACEUTICAL CO LTD0 citations62
AJINOMOTO KK
5 patentsUS5186931AFeb 16, 1993
Composition and method for supporting bone marrow transplantation
AJINOMOTO KK32 citations92
US5362489ANov 8, 1994
Use of recombinant B-cell differentiation factor for augmenting antibody production and stimulating bone marrow proliferation
AJINOMOTO KK8 citations73
US5126325AJun 30, 1992
Method for treating thrombocytopenia
AJINOMOTO KK13 citations73
US5541088AJul 30, 1996
Recombinant process of producing non-glycosylated B-cell defferentiation factor
AJINOMOTO KK5 citations62
US5310550AMay 10, 1994
Method of treating thrombocytopenia using human BCDF in combination with IL-3
AJINOMOTO KK1 citations52
ONO PHARMACEUTICAL CO
3 patentsUS6555555B1Apr 29, 2003
Fused thiophone derivatives and drugs containing the same as the active ingredient
ONO PHARMACEUTICAL CO25 citations90
US6420391B1Jul 16, 2002
Fused thiophone derivatives and drugs containing the same as the active ingredient
ONO PHARMACEUTICAL CO23 citations90
US6770644B1Aug 3, 2004
Hydroxamic acid derivatives, process for the production thereof and drug containing the same as the active ingredient
ONO PHARMACEUTICAL CO0 citations39